Compare Humana Inc (HUM) vs MakeMyTrip Ltd (MMYT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs MakeMyTrip Ltd — how do they compare? Humana Inc trades at $453.46 (market cap $46.49B), while MakeMyTrip Ltd trades at $42.6 (market cap $4.09B). The key difference: Humana Inc is far larger — about 11.4× MakeMyTrip Ltd's market cap, and Humana Inc pays a 0.91% dividend while MakeMyTrip Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and MakeMyTrip Ltd for 12 Days on average.
| HUM | MMYT | |
|---|---|---|
Market Cap | $46.49B | $4.09B |
Volume | 2,567,704 | 1,828,010 |
Sector | Health | Consumer Cyclical |
52-Week High | $409.85 | $94.43 |
52-Week Low | $163.67 | $36.30 |
Typical Hold Time | 53 Days | 12 Days |
Enterprise Value | $53.84B | $4.75B |
Dividend Yield | 0.91% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $396.51, down 1.92% on the day, with strong technical momentum showing bullish moving averages and key support at $391. The company demonstrates consistent revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent quarterly earnings have exceeded expectations, with Q2 2026 EPS of $7.61 beating estimates of $7.27. Analyst sentiment remains positive with a $432.63 consensus price target representing 9% upside potential from current levels.
The investment case centers on Humana's dominant Medicare Advantage position and consistent revenue growth, though margin pressure and regulatory scrutiny present headwinds. With 43% of analysts maintaining buy ratings and institutional accumulation continuing, the stock offers exposure to healthcare demographics but requires monitoring of enrollment trends and cost management execution.
MakeMyTrip (MMYT) trades at $43.41 with minimal daily movement (+0.09%). The stock shows mixed technical signals with a bearish overall trend but oversold RSI readings. Fundamentally, the company maintains strong revenue growth (2025: $978M, 2026: $1.1B) and a robust gross margin of 73.45%, though net margins have compressed from 9.72% to 3.22%. Recent earnings show volatility with one beat and two misses in the last four quarters.
Wall Street maintains strong bullish sentiment with a $77 consensus price target (72.7% buy ratings), representing 77% upside potential. Key risks include declining profitability margins, significant debt increase forecasted for 2026, and competitive pressures in the travel sector. The planned Indian subsidiary IPO could unlock value but execution remains critical.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About MakeMyTrip Ltd
MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →
